Question 1

What are the key details for the project “Eli Lilly $6 Billion Active Drug Ingredient Manufacturing Facility”?

Accepted Answer

The project “Eli Lilly $6 Billion Active Drug Ingredient Manufacturing Facility” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Huntsville, Alabama, United States. Taiyo aggregates data on it from TradingView.

Question 2

What is the latest status of the project “Eli Lilly $6 Billion Active Drug Ingredient Manufacturing Facility”?

Accepted Answer

The status recorded for “Eli Lilly $6 Billion Active Drug Ingredient Manufacturing Facility” is planned.

Question 3

What is the budget and commercial profile for the project “Eli Lilly $6 Billion Active Drug Ingredient Manufacturing Facility”?

Accepted Answer

Taiyo normalizes the budget of “Eli Lilly $6 Billion Active Drug Ingredient Manufacturing Facility” to USD 6000000000.

Question 4

Where can I verify the source and access all details for “Eli Lilly $6 Billion Active Drug Ingredient Manufacturing Facility”?

Accepted Answer

This Taiyo project page references TradingView along with the original URL (https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3XF1HH:0-eli-lilly-to-build-6-billion-alabama-plant-as-part-of-us-manufacturing-push/). Taiyo standardizes official data into a consistent, searchable project profile.

Original status	planned
Taiyo status	Prospective
Taiyo last update	2026-07-22

Description	Eli Lilly will invest more than $6 billion to build a new active drug ingredient manufacturing facility in Huntsville, Alabama. The plant will produce small-molecule synthetic and peptide medicines, including orforglipron, an oral GLP-1 weight-loss drug. Construction is planned to start in 2026 and complete by 2032, creating about 3,000 construction jobs and 450 permanent roles.
Original sector	Pharmaceutical Manufacturing
Budget

Record type	Project
Sector	Manufacturing (Industrial)
Article published date	2025-12-12

Eli Lilly $6 Billion Active Drug Ingredient Manufacturing Facility

Ask ConstructChat about Eli Lilly $6 Billion Active Drug Ingredient Manufacturing Facility

Project Information

Research

View all details

Country	United States of America (USA)
State	Alabama
City	Huntsville

Eli Lilly $6 Billion Active Drug Ingredient Manufacturing Facility

Ask ConstructChat about Eli Lilly $6 Billion Active Drug Ingredient Manufacturing Facility

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States